ValueScreener

ValueScreener company report

Concentra Group Holdings Parent, Inc. (CON)

NYSE / Healthcare / Medical - Equipment & Services

Share price

39.15 USD Market dataClose of Oct 15, 2026

Market capitalisation

4.99B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 26, 2026
Ratios computed
Oct 15, 2026
Filed years
4, FY2022 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

10.7% Computed

From the FY2025 filing

Read quality

Valuation

Price to earnings

30.12x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

3.9% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

FY2021 Revenue: 1.73B USDFY2021 Net income: 208.9M USDFY2022 Revenue: 1.72B USDFY2022 Net income: 166.7M USDFY2023 Revenue: 1.84B USDFY2023 Net income: 179.9M USDFY2024 Revenue: 1.90B USDFY2024 Net income: 166.5M USDFY2025 Revenue: 2.16B USDFY2025 Net income: 166.4M USD
Revenue Net income5 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.
Named tests met
2 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 30.12x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 25.00x and 40.00x.

Today, against the Healthcare sector (223 companies), 30.12x sits at the 58th percentile; the middle half of that group runs from 13.52x to 42.98x.

Is it good

Return on invested capital was 10.7% in FY2025, in the band labelled "Around the cost of capital" (8.0% to 12.0%), on lines anchored on Damodaran's cost-of-capital data.

Today, against the Healthcare sector (233 companies), 10.7% sits at the 71st percentile; the middle half of that group runs from -37.4% to 12.8%.

Is it safe

Interest coverage was 3.06x in FY2025, in the band labelled "Investment grade" (3.00x to 6.00x), on lines anchored on Damodaran's interest-coverage table.

Year by year against peers
Whether Concentra Group Holdings Parent, Inc.'s return on invested capital stayed above the median of the Healthcare sector, year by year. (FY2023 to FY2025, 3 fiscal years of Concentra Group Holdings Parent, Inc. with a comparable figure)
The direction
Which way Concentra Group Holdings Parent, Inc.'s operating margin has moved, and how steadily. (FY2021 to FY2025, 5 filed years of Concentra Group Holdings Parent, Inc.)
What could explain it
What in Concentra Group Holdings Parent, Inc.'s filed statements could explain the movements. (7 readings drawn from the statement lines Concentra Group Holdings Parent, Inc. filed)
What to check next
What to check next on Concentra Group Holdings Parent, Inc., and where in its filings. (4 questions for Concentra Group Holdings Parent, Inc.)
In one paragraph
One paragraph on Concentra Group Holdings Parent, Inc.'s returns, cash, balance sheet and price. (14 of sixteen figures read for Concentra Group Holdings Parent, Inc.)

These are CON’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research CONPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 26, 2026, accession 0002014596-26-000029.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Concentra Group Holdings Parent, Inc: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax10.7% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Return on equity42.3% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Return on capital employed, pre-tax13.3% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Return on assets5.8% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Gross margin
Why n/a

Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Operating margin15.4% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Net margin7.7% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
CON 7.7%
OPCH 3.7%INDV 16.9%STVN 11.8%LFST 0.7%CHE 10.5%
0.7%16.9%
Net margin: CON against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Concentra Group Holdings Parent, Inc: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity5.35 ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Current ratio1.14 ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Quick ratio1.14 ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Interest coverage3.06x ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Altman Z-score2.47 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Net debt2.02B ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Total assets 2.86BTotal liabilities 2.44BShareholders' equity 393.3MOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Concentra Group Holdings Parent, Inc owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 26, 2026, 0002014596-26-000029).

Concentra Group Holdings Parent, Inc: balance sheet position
Total assets2.86B FiledFY2025 10-K, filed Feb 26, 2026
Total liabilities2.44B FiledFY2025 10-K, filed Feb 26, 2026
Shareholders' equity393.3M FiledFY2025 10-K, filed Feb 26, 2026
Cash79.9M FiledFY2025 10-K, filed Feb 26, 2026
Total debt2.10B FiledFY2025 10-K, filed Feb 26, 2026
Net debt2.02B
Current ratio1.14
Debt to equity5.35

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Concentra Group Holdings Parent, Inc: what the market charges, each with its source
FigureValue, source and document
Price to earnings30.12x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
P/E on trailing twelve months24.22x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book12.77x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Price to sales2.32x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Enterprise value to EBIT21.10x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Enterprise value to EBITDA17.20x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Price to earnings over growth
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Diluted earnings per share1.30 USD FiledFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Graham number9.47 USD ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029

We publish no fair value or price target of our own. Value CON on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Concentra Group Holdings Parent, Inc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Concentra Group Holdings Parent, Inc: valuation
Share price39.15 USD
Market capitalisation4.99B USD
Enterprise value to EBITDA17.20x
Graham number9.47 USD
Diluted earnings per share, FY20251.30 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Nov 6, 2024: low 10.21x, median 13.96x, high 24.22x, latest 24.22x. 484 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Concentra Group Holdings Parent, Inc

  1. Option Care Health, Inc. (OPCH)Market cap 4.68B USD
  2. Indivior Pharmaceuticals Inc (INDV)Market cap 4.20B USD
  3. Stevanato Group S.p.A. (STVN)Market cap 5.25B USD
  4. LifeStance Health Group, Inc. (LFST)Market cap 4.73B USD
  5. Chemed Corporation (CHE)Market cap 6.74B USD

Same sector (Healthcare) and size band (Mid, 2B to 10B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Concentra Group Holdings Parent, Inc: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield3.9% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Free cash flow197.1M USD ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Free cash flow margin9.1% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Dividend yield0.6% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Payout ratio19.3% ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
FY2021 Free cash flow: 243.9M USDFY2021 Net income: 208.9M USDFY2022 Free cash flow: 228.4M USDFY2022 Net income: 166.7M USDFY2023 Free cash flow: 169.4M USDFY2023 Net income: 179.9M USDFY2024 Free cash flow: 210.3M USDFY2024 Net income: 166.5M USDFY2025 Free cash flow: 197.1M USDFY2025 Net income: 166.4M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Concentra Group Holdings Parent, Inc.: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
30.12xFY2025Oct 15, 2026
12.77xFY2025Oct 15, 2026
21.10xFY2025Oct 15, 2026
3.9%FY2025Oct 15, 2026
10.7%FY2025Feb 26, 2026
0.6%FY2025Oct 15, 2026
5.35FY2025Feb 26, 2026
1.14FY2025Feb 26, 2026
2.32xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a This figure compares a year against the one before it, and we hold one filed year for this company.
2.47FY2025Oct 15, 2026
-2.40FY2025Feb 26, 2026
5/9FY2025Feb 26, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 4 filed fiscal years on record, FY2022 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

5 fiscal years, FY2021 to FY2025. 4 read from the annual reports Concentra Group Holdings Parent, Inc filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in USD, as reported.

Concentra Group Holdings Parent, Inc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY20252.16B334.0M166.4M1.30197.1M15.4%42.3%10-K, Feb 26, 20260002014596-26-000029
FY20241.90B304.8M166.5M1.46210.3M16.0%60.4%10-K, Mar 3, 20250002014596-25-000011
FY20231.84B287.6M179.9M1.73169.4M15.7%15.6%10-K, Mar 3, 20250002014596-25-000011
FY20221.72B258.5M166.7M1.60228.4M15.0%n/a10-K, Mar 3, 20250002014596-25-000011
FY20211.73B270.3M208.9M1.65243.9M15.6%n/aMarket data, supplied Oct 15, 2026accession n/a
  • Revenue, compound annual growth FY2021 to FY2025: 5.7%
  • Earnings, compound annual growth FY2021 to FY2025: -5.5%
  • Earnings per share, compound annual growth FY2021 to FY2025: -5.8%
  • Free cash flow, compound annual growth FY2021 to FY2025: -5.2%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Concentra Group Holdings Parent, Inc: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-2.40 ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Piotroski F-score5/9 ComputedFY2025 10-K, filed Feb 26, 2026, 0002014596-26-000029
Named tests met2 of 30 Computed
Beta0.65 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 2 met, 28 not met, 0 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
ROIC at or above WACC; Cash-covered dividend
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; High yield, low payout; Dividends and buybacks; Low beta, profitable; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Figures we could not read(6)
  • Positive Earnings Streak: We hold 5 profitable filed years in a row; the test needs 10.
  • PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Rev Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Gross Margin: Our archived statements for this filer carry no gross profit line, so there is nothing to compute a gross margin from and trace back to source. That may be because the filer presents no cost of revenue, or because we have not captured the concept. We do not guess which.
  • Price Tangible Book: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 6 figures could not be read on this company, among them Positive Earnings Streak, PEG Ratio, Eps Growth 5Y. Each blank in the table above names the rest, with its reason.
  • We hold 4 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolioHow this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Margin Notes

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map

Apps

  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.

With your permission, Google Analytics, Microsoft Clarity and HubSpot set cookies to measure how this site and the product are used, including recordings of sessions. Nothing is set unless you allow it. Privacy policy